Barbara R. Paul, M.D.


Dr. Paul serves as an advisor and board member to healthcare companies. In addition to her role on the board of Natus Medical, she serves on the board of Quorum Health Corporation, an owner and operator of general acute care hospitals and outpatient service providers. She served as Senior Vice President & Chief Medical Officer at Community Health Systems (CHS) from July 2007 to January 2015. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.).  Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician. She also worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush. She was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin - Madison and earned her medical degree from Stanford University School of Medicine.

Jonathan A. Kennedy

President, Chief Executive Officer and Director

Jonathan Kennedy joined Natus as Chief Financial Officer in April 2013 and served as General Manager of Natus’ Newborn Care Business Unit from April 2017 to February 2018. Before joining Natus, Mr. Kennedy was Chief Financial Officer of Intersil Corporation, a global semiconductor manufacturer, since 2009. Prior to that, he was Intersil’s Corporate Controller since 2005 and Director of Finance since 2004. Before joining Intersil, Mr. Kennedy held management roles in Finance and Information Technology with Alcon Inc. and Harris Corporation. He holds a Bachelor of Science degree in Business Administration and a Master of Science degree in Accounting from the University of Central Florida.

Joshua H. Levine


Mr. Levine joined the Board in June 2018 and is currently President and Chief Executive Officer at Accuray Incorporated, a manufacturer of radiation oncology systems. Mr. Levine brings extensive experience from a career spanning three decades in the medical device/medical technology industry. Mr. Levine served as President and Chief Executive Officer of Mentor Corporation from 2004 to 2009 and led the company through a strategic transformation prior to its sale to Johnson & Johnson. Mr. Levine spent a total of 15 years at Mentor, where he held various Sales, Marketing and Management roles including Chief Operating Officer and Senior Vice President of Global Sales and Marketing. Prior to Mentor, Mr. Levine served as President and Chief Executive Officer of Immucor Corporation. Mr. Levine holds a Bachelor of Arts degree in Communications from the University of Arizona and has completed Executive Management Programs at Stanford University, Graduate School of Business and the University of Pennsylvania, Wharton School.

Kenneth E. Ludlum


Mr. Ludlum currently serves as a board member and an advisor to private medical and biotechnology companies. Mr. Ludlum served as Chief Financial Officer of CareDx, Inc., a medical diagnostic company, from March 2014 to April 2016. From April 2011 to October 2013, Mr. Ludlum served as Vice President and Chief Financial Officer, and Head of Operations for Endogastric Solutions, Inc., a medical device company. More than five years ago, Mr. Ludlum also serves as CFO for two other publicly –held companies, Perclose, Inc. from 1995 to 2000, and Alteon, Inc. from 1992 to 1994. He has also served on the board of directors and as Chair of the Audit Committee of several public and private medical or biotechnology companies. Mr. Ludlum holds a B.S. in Business Administration from Lehigh University and a M.B.A. from Columbia University Graduate School of Business. Mr. Ludlum brings to the Board over 30 years of business and financial experience working with healthcare and biotechnology companies. His service as chief financial officer at several public companies has provided him with extensive financial and accounting experience, and knowledge of accounting principles, financial reporting rules, and regulations. With his background in investment banking, he also brings a unique perspective to the Board.

Lisa Wipperman Heine


Ms. Heine joined the Board in June 2018 and is currently Chief Executive Officer of PreCardia, Inc., an early stage, private company focused on the treatment of acute decompensated heart failure.  Prior to joining PreCardia, she was Chief Operating Officer at Mitralign, Inc., a venture backed innovator of transcatheter heart valve technologies. Prior to joining Mitralign, she was the Founder and Principal at deArca Strategic Solutions, LLC, a consulting firm focused on helping medtech companies assess, develop and execute strategies related to market opportunities and technology adoption. Lisa has also served in multiple leadership roles at Covidien, Inc., including Global Vice President of Medical Affairs for Vascular Therapies. During her tenure at Covidien, she helped drive the strategy in support of a $1.7B business and was also responsible for leading the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Medical Education functions. Lisa also currently serves as a member of the Board of Directors of Surmodics Inc. She received her undergraduate degree from St. Olaf College and graduate degree from the University of Manitoba.

Alice D. Schroeder


Alice Schroeder serves on the board of Quorum Health Corporation and Prudential plc. She chairs the Quorum Health audit and compliance committees and serves on its nominating and governance committee. She also serves on the Prudential plc audit committee and on its risk committees. From February 2016 until December 2018, Ms. Schroeder chaired Bank of America Merrill Lynch International's (“BAMLI”) audit committee and served on its governance committee.

Ms. Schroeder was CEO and chair from 2014-2017 of WebTuner Corp., a Seattle-area software developer, through its turnaround and exit through sale in May 2017. Formerly, she was a Managing Director in the equities division of Morgan Stanley, leading the global insurance research team, and before that at PaineWebber and CIBC Oppenheimer, spending nearly two decades on Wall Street. She began her career as a CPA with Ernst & Young and spent two years as a project manager at the Financial Accounting Standards Board, overseeing the issuance of several key accounting standards for the insurance industry.

Ms. Schroeder is author of the #1 New York Times and Wall Street Journal Bestseller The Snowball: Warren Buffett and the Business of Life.

Thomas J. Sullivan


Tom Sullivan has served as President and CEO of A&E Medical Corporation since 2018. From 2011 to 2018, Mr. Sullivan served as President and CEO of two public companies: Symmetry Surgical, Inc., a medical device company serving the Neuro and General Surgery markets, and its predecessor, Symmetry Medical, Inc., a leading global contract manufacturer of surgical instruments, sterilization cases and trays, and orthopedic implants. Prior to joining Symmetry Medical in 2011, Mr. Sullivan was President, Supply Chain & Business Processes, Johnson & Johnson Health Care Systems Inc.; President of Depuy Orthopeadics, Inc., a Johnson & Johnson Company; and President of Johnson & Johnson Medical Products Canada. Mr. Sullivan began his career at Johnson & Johnson in 1990 in the areas of strategic planning and operations. Mr. Sullivan graduated as a Palmer Scholar from The Wharton School in 1991 where he earned an MBA in Strategic Management and Management Information Systems. He also holds a Bachelor of Science degree in Computer Science and Applied Mathematics from the University of Pittsburgh.